KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $135.1 million.

  • Medpace Holdings' Net Income towards Common Stockholders rose 1548.05% to $135.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $451.1 million, marking a year-over-year increase of 1155.75%. This contributed to the annual value of $451.1 million for FY2025, which is 1155.75% up from last year.
  • Per Medpace Holdings' latest filing, its Net Income towards Common Stockholders stood at $135.1 million for Q4 2025, which was up 1548.05% from $111.1 million recorded in Q3 2025.
  • Medpace Holdings' Net Income towards Common Stockholders' 5-year high stood at $135.1 million during Q4 2025, with a 5-year trough of $39.9 million in Q2 2021.
  • For the 5-year period, Medpace Holdings' Net Income towards Common Stockholders averaged around $78.3 million, with its median value being $71.7 million (2023).
  • The largest annual percentage gain for Medpace Holdings' Net Income towards Common Stockholders in the last 5 years was 6567.37% (2021), contrasted with its biggest fall of 163.57% (2021).
  • Quarter analysis of 5 years shows Medpace Holdings' Net Income towards Common Stockholders stood at $50.0 million in 2021, then soared by 37.25% to $68.7 million in 2022, then increased by 14.02% to $78.3 million in 2023, then skyrocketed by 49.45% to $117.0 million in 2024, then rose by 15.48% to $135.1 million in 2025.
  • Its last three reported values are $135.1 million in Q4 2025, $111.1 million for Q3 2025, and $90.3 million during Q2 2025.